Reduced glutathione is the main source of thiol groups in most living cells
Weight & obesity research Investigated in early human obesity trials
Unlike programs that lean on aggressive marketing or ambiguous scientific claims, Sprout Health presents its services with clarity, honesty, and structure
In retatrutide trials, people on placebo experienced minimal changes in hunger or number of calories consumed relative to the drug group
It also reduces blood loss, bruising and trauma, making you feel better and stronger
Clinical Effectiveness: SURMOUNT-1 Trial (Tirzepatide 15 mg): Duration: 72 weeks Participants: 2,539 adults with obesity Average Weight Loss: 22.5% of body weight 10 mg Dose: 21.4% weight loss 5 mg Dose: 15.0% weight loss Placebo: 2.4% weight loss 5% Weight Loss: 96% of participants 10% Weight Loss: 89% of participants 15% Weight Loss: 78% of participants 20% Weight Loss: 63% of participants This is the best weight loss result ever achieved with medication in clinical trials